ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Regeneron Announces Positive Topline Results from Evinacumab Trial
August 15, 2019Regeneron Pharmaceuticals announced positive pivotal Phase 3 results for evinacumab, an investigational angiopoietin-like 3 (ANGPTL3) antibody, in patients with homozygous familial hypercholesterolemia (HoFH). -
Dupixent Showed Positive Topline Results in Trial for Children
August 08, 2019Regeneron and Sanofi announced a pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat severe atopic dermatitis in children aged 6 to 11 years met its primary and secondary endpoints.
Pharma Sources Insight January 2025
